Predicting tumor response in breast cancer patients using diffuse optical tomography
Jacqueline Gunther(Columbia University), Andreas H. Hielscher(New York University), Kevin Kalinsky(Emory University), Susan Refice(Columbia College), Molly Flexman(Philips (United States)), Mindy A. Brown(Columbia University), Emerson A. Lim(Columbia University), Dawn L. Hershman(Columbia University), Hyun Keol Kim(Columbia University)
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
June 14, 2013
Cited by 3
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
American Society of Clinical Oncology Position Statement on Obesity and Cancer
|Journal of Clinical Oncology|2014|524